Previous symbols: PGL3. Aliases: CYB560, cybL.
SDHC encodes the large cytochrome b560 transmembrane subunit of succinate dehydrogenase (SDH, Complex II), a heterotetrameric enzyme (SDHA/SDHB/SDHC/SDHD) embedded in the mitochondrial inner membrane. Together with SDHD, SDHC forms the membrane anchor domain of Complex II, contributing to the ubiquinone (CoQ) binding site and harboring the heme b (cytochrome b560) prosthetic group shared between the two membrane subunits. SDHC has three transmembrane helices and provides key residues (Ile56, Trp61, Met65, Ile69) that directly contact ubiquinone at the Q-site. The heme b is axially coordinated by His127 of SDHC and the corresponding histidine of SDHD. SDHC has no independent catalytic activity; its role is structural (membrane anchoring, heme environment, Q-site formation). Complex II uniquely links the TCA cycle and the electron transport chain by catalyzing succinate oxidation to fumarate (at SDHA) and transferring electrons to ubiquinone at the SDHC/SDHD membrane interface, but does NOT pump protons. SDHC functions as a tumor suppressor; germline loss-of-function mutations and promoter hypermethylation cause paraganglioma/ pheochromocytoma (PPGL3), gastrointestinal stromal tumors (GIST), and Carney triad, via succinate accumulation and pseudohypoxic signaling.
Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.
| Disorder | Relationship | Where the gene appears |
|---|---|---|
| Hereditary Pheochromocytoma-Paraganglioma Syndrome | causative | |
| Carney-Stratakis syndrome |
untyped
Germline Loss-of-Function Variants
|
mechanism: Germline SDH complex loss of function
|
| Pheochromocytoma and Paraganglioma |
untyped
Germline Loss-of-Function Mutations
|
mechanism: Succinate Dehydrogenase Complex Dysfunction
subtype: PGL3
|
An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.
| ClinGen disease | MOI | Classification | dismech entry |
|---|---|---|---|
| hereditary pheochromocytoma-paraganglioma MONDO:0017366 | AD | Definitive 2021-06-17 |
|
| mitochondrial disease MONDO:0044970 | UD | No Known Disease Relationship 2022-03-07 |
no dismech entry |
Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.